rs3732341

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000460788.5(KIF1A):​n.3170C>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.37 in 151,770 control chromosomes in the GnomAD database, including 12,166 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.37 ( 12148 hom., cov: 30)
Exomes 𝑓: 0.43 ( 18 hom. )

Consequence

KIF1A
ENST00000460788.5 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.00200

Publications

8 publications found
Variant links:
Genes affected
KIF1A (HGNC:888): (kinesin family member 1A) The protein encoded by this gene is a member of the kinesin family and functions as an anterograde motor protein that transports membranous organelles along axonal microtubules. Mutations at this locus have been associated with spastic paraplegia-30 and hereditary sensory neuropathy IIC. Alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Apr 2012]
KIF1A Gene-Disease associations (from GenCC):
  • intellectual disability, autosomal dominant 9
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • syndromic intellectual disability
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • neuropathy, hereditary sensory, type 2C
    Inheritance: AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • hereditary spastic paraplegia 30
    Inheritance: AR, AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
  • autosomal dominant non-syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • PEHO syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary sensory and autonomic neuropathy type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 2-240716127-G-A is Benign according to our data. Variant chr2-240716127-G-A is described in ClinVar as Benign. ClinVar VariationId is 335240.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.479 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KIF1ANM_001244008.2 linkc.*1237C>T 3_prime_UTR_variant Exon 49 of 49 ENST00000498729.9 NP_001230937.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KIF1AENST00000498729.9 linkc.*1237C>T 3_prime_UTR_variant Exon 49 of 49 5 NM_001244008.2 ENSP00000438388.1

Frequencies

GnomAD3 genomes
AF:
0.370
AC:
56029
AN:
151474
Hom.:
12144
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.160
Gnomad AMI
AF:
0.503
Gnomad AMR
AF:
0.406
Gnomad ASJ
AF:
0.554
Gnomad EAS
AF:
0.199
Gnomad SAS
AF:
0.271
Gnomad FIN
AF:
0.455
Gnomad MID
AF:
0.513
Gnomad NFE
AF:
0.483
Gnomad OTH
AF:
0.420
GnomAD4 exome
AF:
0.426
AC:
75
AN:
176
Hom.:
18
Cov.:
0
AF XY:
0.464
AC XY:
52
AN XY:
112
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
6
American (AMR)
AF:
0.500
AC:
1
AN:
2
Ashkenazi Jewish (ASJ)
AF:
0.500
AC:
1
AN:
2
East Asian (EAS)
AF:
0.395
AC:
34
AN:
86
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2
European-Finnish (FIN)
AF:
0.625
AC:
5
AN:
8
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.516
AC:
33
AN:
64
Other (OTH)
AF:
0.167
AC:
1
AN:
6
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.370
AC:
56045
AN:
151594
Hom.:
12148
Cov.:
30
AF XY:
0.368
AC XY:
27241
AN XY:
74054
show subpopulations
African (AFR)
AF:
0.160
AC:
6603
AN:
41336
American (AMR)
AF:
0.406
AC:
6186
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.554
AC:
1925
AN:
3472
East Asian (EAS)
AF:
0.199
AC:
1018
AN:
5122
South Asian (SAS)
AF:
0.272
AC:
1298
AN:
4776
European-Finnish (FIN)
AF:
0.455
AC:
4765
AN:
10484
Middle Eastern (MID)
AF:
0.500
AC:
147
AN:
294
European-Non Finnish (NFE)
AF:
0.483
AC:
32766
AN:
67838
Other (OTH)
AF:
0.417
AC:
880
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1589
3178
4766
6355
7944
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
524
1048
1572
2096
2620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.439
Hom.:
14992
Bravo
AF:
0.359
Asia WGS
AF:
0.232
AC:
805
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hereditary spastic paraplegia 30 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
3.3
DANN
Benign
0.56
PhyloP100
-0.0020
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3732341; hg19: chr2-241655544; API